.
Hydroxychloroquine No More Effective Than Placebo in Preventing COVID-19 _________________
New COVID studies: Remdesivir yes, hydroxychloroquine noOct 09, 2020
The New England Journal of Medicine (NEJM) yesterday published the results of two randomized, controlled trials on two medications for the treatment of COVID-19, one supporting previous studies that found that Gilead Sciences' antiviral drug remdesivir helps patients recover faster and one adding to mounting evidence that the antimalarial drug
hydroxychloroquine is no better than a placebo at preventing death in hospital patients
https://www.cidrap.umn.edu/news-perspective/2020/10/new-covid-studies-remdesivir-yes-hydroxychloroquine-noSeptember 30, 2020 Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
A Randomized Clinical Trial Published online September 30, 2020.
Finding In this double-blind, placebo-controlled randomized clinical trial that included 132 participants and was terminated early,
there was not a significant difference in reverse-transcriptase polymerase chain reaction–confirmed SARS-CoV-2 incidence between hydroxychloroquine and placebo cohorts.https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771265 Hydroxychloroquine No More Effective Than Placebo in Preventing COVID-19 Penn clinical trial shows health care workers in contact with COVID-19 patients who took hydroxychloroquine daily did not reduce their rate of infection
September 30, 2020
PHILADELPHIA— In a clinical trial testing whether a daily regimen of hydroxychloroquine could protect those most likely to be exposed to COVID-19, researchers from the Perelman School of Medicine at the University of Pennsylvania found there was
no difference in infection rates among health care workers who took the drug versus those taking a placebo.https://www.pennmedicine.org/news/news-releases/2020/september/hydroxychloroquine-no-more-effective-than-placebo-in-preventing-covid19Hydroxychloroquine didn't prevent COVID-19 among healthcare workers in new studyOct 1, 2020
The malaria drug
hydroxychloroquine — which President Trump said he took in the hope of warding off COVID-19 —
was found not to prevent infections among volunteers in a study released on Wednesday.
The study, which was ended early, included 125 healthcare workers, some of whom took hydroxychloroquine daily for eight weeks, while the others took a placebo.
https://www.9news.com.au/world/hydroxychloroquine-didnt-prevent-covid19-among-health-care-workers-in-new-study-donald-trump/53999c3b-3a90-4285-973d-8242748dc6e4hydroxychloroquine.
